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Abstract
 .The effects of phorbol esters phorbol-12,13-dibutyrate, PDB on alpha-fetoprotein expression and cell growth were
 .assayed by using fetal hepatocytes in primary culture. PDB acts synergistically with epidermal growth factor EGF to
 .specifically decrease alpha-fetoprotein AFP mRNA levels, without affecting the expression of other genes of the same
 .family, such as albumin and Vitamin D-binding protein DBP . This effect is PDB-dose dependent, maximal effects being at
 .  .10 ngrml. The implication of protein kinase C PKC in this effect seems clear since bisindolylmaleimide BIS , a specific
PKC inhibitor, completely blocks the PDB effect on AFP expression. Nuclear run-on experiments show that the decrease in
AFP mRNA levels is mainly due to an inhibition in the transcription rate of the gene. Determination of PKC activities
shows that fetal hepatocytes contain mainly Ca2q-independent isoenzymes, which patterns of activation was not modified
by EGF plus PDB treatment with respect to PDB treatment. We have found that MAPK and JNK activities, c-jun and c-fos
mRNA levels and AP-1 binding activity are notably increased when cells are incubated with both EGF and PDB. PDB does
w xnot stimulate growth of fetal hepatocytes, measured either as 3H -thymidine incorporation into DNA or by cell cycle
analysis using flow cytometry. All these results suggest that activation of PKC may affect liver gene expression rather than
cell growth in fetal hepatocytes. q 1998 Elsevier Science B.V.
Keywords: Fetal hepatocyte; Alpha-fetoprotein; Protein kinase C; Phorbol ester; Epidermal growth factor
Abbreviations: AFP, alpha-fetoprotein; BIS, bisindolylmaleimide; DBP, vitamin D-binding protein; EGF: epidermal growth factor;
HGF, hepatocyte growth factor; JNK, JUN-Nterminal-kinase; MAPK, mitogen-activated protein kinase; PDB, phorbol-12,13-dibutyrate;
PEPCK: phosphoenol-pyruvate carboxykinase; PKC, protein kinase C; TGF-a , transforming growth factor-a
) Corresponding author. Fax: q34-1-3941779; E-mail: ceronce@eucmax.sim.ucm.es
1 Present address: Departement de Biologie du Developpement, Institut Jacques Monod, CNRS, Universite Paris VII. 2 Place Jussier,´ ´
Tour 43. 75251 Paris Cedex, France.
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
 .PII S0167-4889 98 00005-6
( )C. Roncero et al.rBiochimica et Biophysica Acta 1402 1998 151–164152
1. Introduction
 .The control of albumin and alpha-fetoprotein AFP
gene expression in the mammalian liver provides a
powerful model system for investigating the molecu-
lar mechanisms of gene regulation during normal
development and carcinogenesis. AFP is the most
abundant plasma protein during the fetal period. It is
expressed at a high rate in the yolk sac, the fetal liver
and to a lesser extent in the fetal gut. Transcription of
the AFP gene drops around birth and is totally blocked
during normal adult life. In contrast, the plasma
albumin concentration increases from low levels dur-
ing fetal life to high levels in the adult when it
becomes the major serum protein. AFP expression
can be resumed under certain pathophysiological con-
ditions, such as liver regeneration after chemical
w xinjury and in hepatocarcinogenesis 1,2 . The AFP
gene expression is mainly regulated at the transcrip-
tional level. The promoter region confers the liver
specificity of expression and upstream positive and
negative regulatory elements can also control the
transcription rate of the gene for review, see Ref.
w x.3 . Several of the liver-enriched transcription factors
which may participate in the functioning of the AFP
promoter and enhancers in the liver have been well
w xcharacterized 4–9 .
 .The protein kinase C PKC serine–threonine ki-
nases, a family of at least 12 isoenzymes with distinct
tissue distribution characteristics, were first character-
ized on the basis of its activation in vitro by Ca2q,
phospholipids and diacylglycerol and extensive evi-
dence is available for their involvement in a variety
of physiological processes, including control of cell
w xproliferation andror differentiation 10–12 . Certain
PKC isotypes are also the major receptor for tumor-
promoting phorbol esters, which activate the kinase
in vitro in a manner very similar to diacylglycerol
 w x.for a review, see Ref. 13 . For this, phorbol esters
have been widely used as a pharmacological tool to
investigate the role of PKC pathway in the cell.
Primary cultures of fetal hepatocytes may be used
as a powerful model for studying the mechanisms
that control liver proliferation and gene expression
around birth. These cells respond to growth factors,
such as EGF, HGF, TGF-a , inducing DNA synthesis
w xand mitosis 14,15 . In addition, growth factors and
hormones can regulate the expression of some liver
specific genes, inducing the final differentiation of
w xthe hepatocytes 16–19 . In the present study, in
order to evaluate the role of the PKC pathway on
fetal liver growth and differentiation, we have studied
the regulation of fetal hepatocyte gene expression and
 .proliferation by phorbol-12, 13-dibutyrate PDB . The
results show that phorbol esters and EGF act syner-
gistically to decrease specifically AFP mRNA levels
in these cells by inhibiting the transcription rate of
the gene. We also observed that PDB does not stimu-
late growth of fetal hepatocytes. All these results
suggest that activation of PKC in fetal hepatocytes is
not related to growth stimulation but to cell differen-
tiation in fetal hepatocytes in primary culture.
2. Materials and methods
2.1. Materials
Fetal and neonatal calf serum and culture media
 .were from Imperial Laboratories Hampshire, UK .
 .Radiochemicals were from ICN Irvine, CA . Multi-
primer DNA labelling system was from Amersham
 .Buckinghamshire, UK . The nick-translation la-
belling system was from Gibco BRL Gaithersburg,
.USA . PDB, BIS and crystal violet were from Sigma
 .St. Louis, MO .
2.2. Methods
2.2.1. Isolation and culture of rat hepatocytes
Hepatocytes from 20-day old foetuses of Wistar
rats were isolated, purified and plated in M-199
w xarginine-free medium 20 , 10% fetal calf serum, as
w xdescribed previously 18,21 . After attachment of the
 .cells 4 h , media was changed and replaced by 2%
new-born bovine serum, M-199 arginine-free
medium. After 18–20 h, the medium was replaced
for one of the same composition but in the absence of
serum and phorbol esters, andror growth factors
were added.
2.2.2. cDNA probes
 .The cloned alpha-fetoprotein AFP cDNA used
w xwas pGRAFP65 22 , the cloned albumin cDNA used
w xwas pRSA13 23 . The rat Vitamin D binding protein
 .DBP cDNA was cloned after PCR, using a set of
primers deduced from the published cDNA sequence
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w x24,25 . Mouse c-jun cDNA probe was the BamH1-
w xfragment of plasmid pRSV c-jun 26 which was a
gift from Dr. M. Yaniv, Paris. Mouse v-fos cDNA
 . w xwas from Oncor Gaithersburgh, MD 27 . 18S Ri-
bosomal probe was a gift from Dr. Rozengurt, Lon-
w xdon 28 .
2.2.3. RNA extraction and Northern blot hybridiza-
tion
Total cellular RNA from cultured rat hepatocytes
was isolated essentially as described by Chomczyn-
w xsky and Sacchi 29 . For Northern blot analysis,
samples containing 5–10 mg of total RNA were
denatured, separated by size on gels containing 0.9%
agarose and 0.66 M formaldehyde and blotted on
GeneScreene membranes New England Nuclear
.Research Products, Boston, MA . The membranes
were hybridized with the corresponding cDNA probes
w 32 x labelled with a P -dCTP by nick translation al-
bumin, ALB, a-fetoprotein, AFP, Vitamin D-binding
.protein, DBP and 18S ribosomal cDNAs or by ran-
 .dom priming reaction c-fos and c-jun . Densitomet-
ric quantification of the autoradiograms was per-
formed in a Molecular Dynamics scanning laser den-
 .sitometer Sunnyvale, CA, USA .
2.2.4. Nuclear run-on transcription assays
Nuclei were isolated from the pooled cells of
w x10–12 plates 30 and stored at y708C in 50 mM
Hepes, pH 7.9, 150 mM NaCl, 0.1 mM EDTA, 5
mM dithiothreitol, 0.125 mM phenylmethylsulfonyl
fluoride and 50% glycerol. The ‘in vitro’ elongation
w x w32 xreactions were carried out as described 31 . P -
labelled RNA transcripts were purified by the method
w x of Linial et al. 32 using NICK columns Pharmacia
.LKB Biotechnology and following the manufac-
turer’s instructions. Denaturation of DNA probes,
application of DNA to GeneScreen membranes, hy-
w32 xbridization of the P -labelled RNA transcripts to
the membrane-bound DNA, post-hybridization
washes, and autoradiography were carried out as
w xdescribed by Roncero and Goodridge 33 .
2.2.5. Measurement of enzyme acti˝ities
To measure PKC activity, the hepatocytes pellets
were homogenized in 0.5 ml of ice-cold 0.25 mM-
sucrose containing 10 mM b-mercaptoethanol, 1 mM
EGTA, 1 mM EDTA, 1 mM phenylmethanesulpho-
 .nyl fluoride PMSF , 10 mg of leupeptinrml and 20
 .mM Hepes, pH 7.4 buffer A . The homogenate was
centrifuged at 105 000=g for 30 min, yielding a
 .soluble and a particulate fraction pellet . To extract
the membrane-bound enzyme, the pellet was resus-
pended in 0.5 ml of buffer A supplemented with
0.1% Nonidet P-40, followed by centrifugation
 .105 000=g for 20 min . The soluble and mem-
brane-bound extracted enzymes were partially puri-
 .fied by chromatography on DEAE-cellulose DE52
after elution with 150 mM NaCl to remove the
inhibitors of the enzyme present in the homogenate.
The activity of PKC was monitored by the phospho-
rylation of histone H1 in the absence and presence of
Ca2q, phosphatidylserine and DAG as previously de-
w xscribed 34 . One unit of PKC was defined as incor-
porating 1 nmol phosphate into histone H1rmin.
Endogenous phosphorylation was negligible.
To measure PKC z activity, fetal hepatocytes,
either untreated or stimulated, were extracted with
lysis buffer 50 mM Tris pH 7.5, 150 mM NaCl, 1%
Triton X-100, 1 mM EGTA, 2 mM EDTA, 1 mM
.PMSF and 25 mgrml of leupeptin and aprotinin and
immunoprecipitated with anti-PKC z antiserum. Im-
mune complexes were washed 5= with ice-cold
lysis buffer supplemented with 0.5 M NaCl and twice
  .with kinase buffer 35 mM Tris pH 7.5 , 10 mM
.MgCl , 0.5 mM EGTA and 1 mM Na VO . The2 3 4
kinase reaction was performed in 20 ml kinase buffer
 w 32 x .containing 60 mM ATP 1 mCi g- P ATP and 1
mg MBP as a substrate for 30 min at 308C and was
terminated by the addition of 4= SDS-PAGE sample
buffer followed by heating for 5 min at 958C. Sam-
ples were resolved in 12% SDS-PAGE and gels were
dried and subjected to autoradiography.
For JNK assay, cells, untreated or stimulated with
PDB orrand EGF for 10 min, were washed with cold
PBS, and lysed at 48C in a buffer containing 25 mM
 .HEPES pH 7.5 , 0.3 M NaCl, 1.5 mM MgCl , 0.22
mM EDTA, 0.5 mM DTT, 0.1% Triton X-100, 20
mM b-glycerophosphate, 0.1 mM sodium vanadate,
1 mM phenylmethylsulfonylfluoride and 2 mgrml
leupeptin. The GST c-jun protein, containing the first
79 amino acids of c-jun fused to GST GST c-jun
 ..1–79 provided by Dr. Silvio Gutkind, was grown
in bacteria and harvested following induction with
 .isopropyl-b-thiogalactopyranoside IPTG . Approxi-
mately 1 mg of protein purified on glutathione–
( )C. Roncero et al.rBiochimica et Biophysica Acta 1402 1998 151–164154
agarose beads was used to pull down JNKs from cell
lysates. The protein complexes were washed 3=
with PBS containing 1% NP-40 and 2 mM sodium
 .vanadate, once with 100 mM Tris pH 7.5 , 0.5 M
LiCl and once with kinase reaction buffer 12.5 mM
MOPS, pH 7.5, 12.5 mM b-glycerophosphate, 7.5
mM MgCl , 0.5 mM EGTA, 0.5 mM NaF and 0.52
.mM sodium vanadate . The JNK activity present in
the protein complex was determined by resuspension
in 30 ml of kinase reaction buffer containing 0.3 mCi
w 32 xof g P ATP and 20 mM unlabelled ATP. After 20
min at 308C reactions were terminated by addition of
10 ml of 4= Laemmli buffer. Samples were heated
at 958C for 5 min and analysed by SDS electrophore-
sis on 10% polyacrylamide gels. Autoradiography
was performed with the aid of an intensifying screen.
MBPK activity corresponding to p42rp44MAPKs
was determined in cellular extracts essentially as
w x  .described 35 using myelin basic protein MBP as
substrate.
2.2.6. Western-blot analysis
p44rp42 MAPKs Western blot analysis were car-
w xried out essentially as described 35 , using 10%
SDS-polyacrylamide gels and a polyclonal anti rat
 .  .MAPK R2 ERK1 antibody from UBI 06-182
 .1:1000 dilution that recognizes p44 and p42 MAPK
isoforms. Blots were developed using the ECL sys-
 .tem Amersham .
For Phospho MAPKs Western blot analysis a simi-
lar procedure was followed, using the anti-active
 .MAPKs antibody from Promega V6671 .
2.2.7. Nuclear extract preparation and gel mobility
shift assay
DNA-binding protein extracts from fetal hepato-
cytes were prepared as described by Andrews and
w x 6Faller 36 , starting with 5=10 cells. Cell suspen-
sion was resuspended in 10 mM HEPES–KOH, pH
7.9 at 48C, 1.5 mM MgCl , 10 mM KCl, 0.5 mM2
 .dithiothreitol, 0.2 mM PMSF Buffer A , allowed to
swell on ice for 10 min, and then vorterex for 10 s.
Samples were centrifuged and the supernatant dis-
carded. The pellet was resuspended in cold Buffer C
20 mM HEPES–KOH, pH 7.9, 25% glycerol, 420
mM NaCl, 1.5 mM MgCl , 0.2 mM EDTA, 0.5 mM2
.dithiothreitol, 0.2 mM PMSF , added with 0.75 mg
each of leupeptin, antipain and aprotinin per ml and
incubated on ice during 20 min for high-salt extrac-
tion. Nuclear debris was removed by centrifugation
for 2 min at 48C and the supernatant fraction was
stored at y708C. The gel mobility shift assay was
w xperformed essentially as previously described 37 .
The double-stranded oligonucleotide used as AP-1
probe was the collagenase TPA responsive element,
composed of the following sequence: AGCTTGAT-
GAGTCAGCCGGATC. Labelling was performed by
w 32 xusing Klenow polymerase and a- P -labelled
deoxyadenosine triphosphate. The binding reaction
mixture contained 0.5 ng of doubled-stranded oligo-
 .  .nucleotide probe, 2 mg of poly dI-dC Ppoly dI-dC
and 2 mg of proteins in Buffer C supplemented with
35 mM MgCl . After a 20 min incubation at 48C, the2
mixture was electrophoresed through a 6% polyacryl-
amide gel in 0.25= Tris–borate–EDTA running
buffer for 3–4 h at 120 V at room temperature. The
dried gel was then autoradiographed.
2.2.8. Assay of DNA synthesis
For this assay, cells were cultured in the absence
 .control or in the presence of the different factors for
w3 x48 h. DNA synthesis was determined by H -thymi-
dine incorporation over the last 40 h 0.5 mCirml, 1
.mM thymidine . At the end of the incubation period,
radioactivity in acid precipitable material was deter-
w xmined as previously described 11 . To estimate cell
number, in parallel dishes the remaining viable adher-
ent cells were stained with crystal violet 0.2% in 2%
. w xethanol for 20 min, as previously described 38 .
After this time, plates were rinsed with tap water,
allowed to dry and 1% sodium dodecyl sulfate was
added to solubilize cells. The absorbance of each
plate was read photometrically at 560 nm. Dishes
without cells were processed in parallel to correct for
the non-specific adhesion of crystal violet to the
plastic. Remaining viable cells were calculated as %
absorbance with respect to control cells incubated in
.the absence of growth factors .
2.2.9. Analysis of nuclear DNA content by flow cy-
tometry
The ploidy determination of hepatocyte nuclei was
estimated by flow cytometry DNA analysis as previ-
w xously described 18 . Cells were detached from dishes
by addition of 0.25% trypsin–0.02% EDTA. After
2–3 min, trypsinization was stopped by adding 10%
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fetal calf serum to the culture medium. The DNA
content per nucleus was evaluated in a FACSCAN
 .flow cytometer Becton-Dickinson, San Jose, CA ,
after using the Cycle test DNA reagent kit Becton-
.Dickinson to stain nuclei with propidium iodide.
This analysis was performed using a Double Discrim-
 .inator Module DDM which permits a distinction to
be made between the signals coming from a single
nucleus and the ones produced by two or more
aggregated nuclei. For the computer analysis, only
signals from single nuclei were considered 10 000
.nucleirassay .
3. Results
3.1. Effect of phorbol esters on alpha-fetoprotein and
albumin mRNA le˝els in fetal hepatocytes in primary
culture
We started studying the effects of phorbol-12,13-
 .dibutyrate PDB on fetal hepatocyte albumin and
 .alpha-fetoprotein AFP expression. As we had previ-
ously described that the response of fetal hepatocytes
to extracellular stimuli is clearly dependent on their
w xproliferative state 18 we decided to incubate the
cells with 100 ngrml PDB in the absence or in the
presence of a mitogenic stimulus, i.e., epidermal
 .growth factor EGF, at 20 ngrml . After 24 h, RNA
was extracted and AFP and albumin RNA levels
were analysed by Northern blot hybridization with
the specific probes. Cells showed decreased levels of
AFP mRNA, when both EGF and PDB were present
 .Fig. 1A . In contrast, phorbol esters did not signifi-
cantly affect the expression of albumin, neither alone,
 .nor in the presence of EGF Fig. 1A . Furthermore,
phorbol esters did not modulate the expression of
another gene of the same family, the Vitamin D-bind-
 .  .ing protein DBP not shown results . Thus, it seems
Fig. 1. Effect of phorbol esters on alpha-fetoprotein and albumin
 .mRNA levels in fetal hepatocytes in primary culture. A Fetal
hepatocytes were incubated for 24 h in the absence or in the
 .presence of phorbol-12,13-dibutyrate PDB, at 100 ngrml
 .andror epidermal growth factor EGF, at 20 ngrml . Northern
blot analysis was performed after isolation of total cellular RNA.
LEFT: A representative experiment is shown. RIGHT: Relative
variations in the AFP mRNA levels were calculated after densito-
metric analysis of the autoradiograms and normalization with the
18S ribosomal probe. Results, expressed as % control cells, are
) ))mean"S.E.M. of five independent experiments P -0.05, P
.  .-0.01 vs. control . B Effect of different concentrations of PDB
on the AFP mRNA levels in fetal hepatocytes cultured for 24 h in
the presence of 20 ngrml EGF. The relative variations in the
AFP mRNA levels, calculated as in A, are presented versus PDB
 .concentration. A representative experiment of three is shown. C
Effect of BIS, an inhibitor of protein kinase C, on the decrease in
AFP mRNA levels produced by 24 h-treatment with EGFqPDB
in fetal hepatocytes. Cells were incubated as in A, but in the
presence of 1 mM BIS. LEFT: A representative experiment is
shown. RIGHT: Relative variations in the mRNA levels were
calculated and expressed as in A and are mean"S.E.M. of three
independent experiments.
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that phorbol esters, synergistically with EGF, down-
regulate AFP expression in fetal hepatocytes in pri-
mary culture. Time-course experiments analysing
AFP mRNA levels showed that decay of them by
EGF plus PDB treatment was proportional to time of
 .treatment not shown results .
In order to determine if the activation of protein
kinase C might be involved in the regulation of AFP
by PDB, we performed two different experimental
 .approaches. 1 We first tested the sensitivity of the
PDB action on AFP gene expression by performing a
dose response analysis in cells cultured in the pres-
ence of 20 ngrml EGF. This was done because it is
known that phorbol esters, when used at low concen-
trations, specifically activate PKC without other sec-
 .ondary effects. 2 We studied the action of bisin-
 .dolylmaleimide BIS , a specific inhibitor of protein
w xkinase C 39 , on the effect of phorbol esters and
EGF on AFP mRNA levels. As shown in Fig. 1B, in
the presence of EGF, PDB induced a decrease in AFP
mRNA levels even at concentrations as low as 1–10
ngrml. Furthermore, BIS was able to specifically
block the down-regulating effect of PDB and EGF on
 .AFP gene expression Fig. 1C . Thus, protein kinase
C activity seems to be implicated in the down-regu-
lation of AFP expression induced by PDB and EGF
in fetal hepatocytes.
3.2. Effect of PDB and EGF on transcription rate of
the AFP and albumin genes
In order to know if the synergistic regulatory effect
of EGF and PDB on AFP mRNA levels was at the
transcriptional level, we performed ‘run-on’ experi-
ments with nuclei isolated from cells incubated dur-
ing 2 h with EGF, in the absence or in the presence
of PDB. Results are shown in Fig. 2. The presence of
PDB specifically inhibited the transcription of the
AFP gene, without affecting the transcription of the
 .albumin Fig. 2 or the Vitamin D-binding protein
 .genes not shown results . So, the decrease in AFP
mRNA levels observed in the PDB-treated cells seems
mainly due to the decrease in the transcriptional rate
of this gene.
3.3. Effect of PDB and EGF on PKC acti˝ities
To check if the effect of treatment EGF plus PDB
modified the response to PDB in activating PKC
Fig. 2. Effect of PDB on alpha-fetoprotein and albumin gene
transcription rates in fetal hepatocytes cultured under prolifera-
tive conditions. Fetal hepatocytes were incubated during 2 h in
 .the presence of 20 ngrml epidermal growth factor EGF and in
the absence or in the presence of 100 ngrml phorbol-12,13-di-
 .butyrate PDB . Nuclei were isolated from the pooled cells and
nuclear run-on transcription assay was performed as described in
 .  .Section 2. A A representative experiment is shown. B After
densitometric analysis of the autoradiograms and normalization
with the 18S probe, the relative transcription rate of the albumin
 .  .ALB and alpha-fetoprotein AFP genes in PDB-treated cells
was calculated and expressed relatively to those in non-treated
cells. The mean"S.E.M. of four independent experiments is
shown.
isoenzymes, we measured PKC activity for Ca2q-de-
pendent and independent isoenzymes. We also mea-
sure PKC z , which belongs to the group of atypical
 .PKCs Fig. 3 . Fetal hepatocytes showed mainly PKC
isoenzymes in soluble form, being the Ca2q-indepen-
dent isoenzymes the main source of activity as re-
 .vealed as PKC activity see legend of Fig. 3A . PDB
treatment for 2 min caused a significant increase in
membrane-bound activity and this effect was not
affected by EGF treatment, that per se had not signif-
icant effect on both types of isoenzymes. Western
analysis using specific antibodies for PKC « and d
isoenzymes showed that fetal hepatocytes expressed
both types of proteins and that both were downregu-
lated after 24 h of treatment with PDB or EGF plus
 .PDB treatments data not shown .
PKC z belongs to a third type of PKC isoenzymes
which are not activated by calcium or phospholipids
and has been implicated in proliferation in other
w xcellular types 40 . Analysis of PKC z activity in
fetal hepatocytes showed a basal activity in control
cells. Neither EGF nor PDB treatments caused signif-
icant variations in activity. However, addition of EGF
in conjunction with PDB caused a small decrease
 .  .17% in basal activity Fig. 3B and C .
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Fig. 3. Effect of PDB and EGF on PKC activities. Panel A:
Subcellular distribution for PKC isoenzymes dependent and inde-
pendent of Ca2q. PKC activity was measured in fetal hepatocytes
as described in Section 2 after 2 min of stimulation by none
 .control , EGF, PDB or EGF plus PDB. The total activity of PKC
in controls was 8.16"0.95 and 18.71"1.24 Urmg protein for
Ca2q-dependent and -independent isoenzymes, respectively. Re-
sults are means"S.E.M. of four cell preparations. Panel B: PKC
z activity. PKC z activity was measured in fetal hepatocytes as
described in Section 2 after 10 min of stimulation by none
 .control , EGF, PDB or EGF plus PDB. Panel C shows PKC z
activity as percentage of control. Results are meansqS.E.M. of
four cell preparations. )P -0.05, )) ,††P -0.01, addition vs.
control.
3.4. Effect of PDB and EGF on JNK acti˝ity, on c-fos
and c-jun mRNA le˝els and on AP-1 binding acti˝ity
c-jun and c-fos genes, whose expression and activ-
ities are known to be modulated by both EGF and
phorbol esters, are involved in the mechanism of
action of these compounds on the transcription of
target genes. Most often, they do so by binding as an
 .heterodimer AP-1 to a conserved DNA motif in
regulatory regions of target genes for a review, see
w x.Ref. 41 . Looking for the possible mechanism by
which EGF and PDB may cooperate in regulating
AFP expression, we analysed the effect of these
 .  .compounds on: 1 JNK activity; 2 mRNA levels of
 .c-fos and c-jun; and 3 AP-1 binding activity. Incu-
bations for 10 min time for reaching JNK maximal
.stimulation, not shown results with PDB or EGF
caused a 2.1- and 3.1-fold increase in JNK activity,
respectively. Addition of both agents had an additive
 .effect, reaching a 4.4-fold increase Fig. 4 . Northern
blot analysis revealed that both c-jun and c-fos mRNA
levels were increased 30 min upon treatment with
 .EGF or PDB Fig. 5A , and, in good correlation with
JNK activity results, addition of both factors together
caused a higher level of expression for both genes
 .Fig. 5A . In order to know if the increase in both
JNK activity and c-jun and c-fos mRNA levels corre-
lated with a higher AP-1 binding activity, cells incu-
bated at different times in the presence of EGF
orrand PDB were used to obtain nuclear extracts and
Fig. 4. Effect of PDB and EGF on JNK activity Fetal hepatocytes
were incubated in the absence or in the presence of PDB 100
.  .ngrml , EGF 20 ngrml or both for 10 min. JNK activity was
assayed as described in Section 2. Upper panel: autoradiogram
corresponding to a representative experiment; 32P-labelled prod-
 .uct is indicated by an arrowhead. Data lower panel represent the
mean"S.E.M. of three independent experiments, analysed in
duplicate and expressed as fold increase with respect to untreated
 .cells CON .
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Fig. 5. Effect of PDB and EGF on c-fos and c-jun mRNA levels
and AP-1 binding activity Fetal hepatocytes were incubated in
 . the absence or in the presence of PDB 100 ngrml , EGF 20
.  .ngrml or both EGFqPDB. A Total cellular RNA was isolated
after 30 min of treatment and c-jun, c-fos and albumin as a
.  .control mRNA levels were analysed by Northern blot. B Cells
were collected after 5 h of treatment and nuclear extracts pre-
pared as described in Section 2. A quantity of 2 mg protein were
incubated for 20 min at 48C with 0.5 ng of 32P-labelled doubled
stranded oligonucleotide containing the TPA-responsive element
of the collagenase gene. After this time, an aliquot of the mixture
was electrophoresed through a 6% polyacrylamide gel under
non-denaturing conditions. In both A and B, the autoradiograph
of a representative experiment of three is shown.
gel mobility shift assays were performed, using a
labelled doubled stranded oligonucleotide containing
the collagenase TPA responsive element. Results af-
ter 5 h of treatment are presented in Fig. 5B. At all
 .the times assayed 1.5, 3 and 5 h , we could find a
cooperative effect between EGF and PDB in increas-
ing the AP-1 binding activity.
3.5. Effect of PDB and EGF on MAPKs acti˝ities
 .Mitogen-activated protein kinases MAPKs are
important intermediates in signalling pathways that
transduce extracellular signals into intracellular re-
sponses and have been implicated in a wide array of
physiological processes including cell growth and
differentiation. To determine whether MAPK activa-
tion plays a role in decreasing AFP mRNA levels, we
examined if EGF and phorbol esters could modulate
these activities. We also looked at the consequences
of blocking specific components of the MEKrMAPK
signalling pathway on the response to EGF and PDB.
Both EGF and PDB caused a marked increased in the
 .active forms of MAPKs Fig. 6A , which correlated
 .with phosphorylation of MBP data not shown Addi-
tion of EGF plus PDB caused a similar activation for
 .these proteins data not shown . Pre-treatment of fetal
Fig. 6. Effect of PDB and EGF on MAPK activity: role of
specific inhibitors on MAPK activity and AFP mRNA levels.
Fetal hepatocytes were pre-incubated for 30 min with 50 mM
PD98059 or 1 mM BIS and then in the absence or in the presence
 .  .  .of PDB 100 ngrml , EGF 20 ngrml or PDB plus EGF. A
After 5 min of stimulation cell lysates were used for MAPK
activity and aliquots of 30 mg of soluble protein were separated
by size in 10% SDS-PAGE and transferred to nylon membranes.
 .Antibodies for phospho-MAPK active forms and total MAPK
were used sequentially. Immunoreactive bands were visualized
 .by ECL. A representative experiment out of three is shown. B
Effect of PD98058 on the AFP mRNA levels in fetal hepatocytes
cultured for 24 h in the absence or presence of signals. Total
 .cellular RNA was isolated and AFP and albumin as a control
mRNA levels were analysed by Northern blot. A representative
experiment out of three is shown.
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 .  .Fig. 7. Effect of phorbol esters and PD98059 on the proliferation of fetal hepatocytes in primary culture. A Effect of PDB 100 ngrml
 .  .and PD98059 50 mM on the DNA synthesis induced by EGF 20 ngrml in fetal hepatocytes incubated during 48 h in the presence of
w3 x  .these factors. Assay of DNA synthesis was performed as described in Section 2, by H -thymidine incorporation. B At the same time,
 .the effect of PDB 100 ngrml on cell number was measured as the number of remaining viable adherent cells after staining with crystal
 .violet. In both, A and B, results are expressed as % control non-treated cells and are the mean"S.E.M. of five independent
experiments, where triplicate dishes were analysed for each condition.
w xhepatocytes with MEK inhibitor PD98059 42 or
BIS effectively blocked the activation caused by EGF
or PDB, respectively. In a similar experimental de-
sign, we checked the effect of PD98059 pre-treatment
on AFP mRNA levels in hepatocytes incubated for
 .24 h in the presence of signals Fig. 6B . Pre-treat-
ment with PD98059 abolished the decrease in AFP
mRNA levels caused by EGF plus PDB.
3.6. Role of protein kinase C pathway in the prolifer-
ation of fetal hepatocytes in primary culture
Results presented above showed that phorbol es-
ters down-regulate AFP gene expression most likely
by a protein kinase C-dependent mechanism. We
wanted to know if phorbol esters might be also
implicated in the regulation of growth of fetal hepato-
cytes in primary culture. For this, we analysed the
effect of phorbol esters on DNA synthesis in these
cells. As it is shown in Fig. 7, the presence of PDB
had not any significant effect neither on the incorpo-
w3 xration of H -thymidine in fetal hepatocytes nor on
the cell number. Furthermore, this compound did not
affect DNA synthesis induced by EGF, i.e., there was
not any synergistic effect between EGF and PDB on
the proliferation of fetal hepatocytes in primary cul-
ture. However, pre-treatment of hepatocytes with
PD98059, totally blocked the proliferative signal in-
 .duced by EGF Fig. 7 . A more detailed analysis of
the cell cycle of these cells after incubation in the
presence of EGF orrand PDB revealed identical
 .results Table 1 . EGF induced the entry of fetal
hepatocytes in cell cycle, decreasing the proportion of
cells in G1 and increasing those in S and G2rM
w xphases, as we had previously described 14 . How-
Table 1
Cell cycle analysis of fetal hepatocytes cultured in the absence or
in the presence of EGF andror PDB
G1 S G2qM
Control 87.5"0.5 7.2"0.9 5.2"0.2
)) )) )EGF 81.0"1.0 12.0"1.8 6.9"0.9
PDB 87.5"1.5 7.4"0.5 4.8"0.9
)) )) )EGFqPDB 79.5"1.5 12.3"2.8 7.9"1.5
 .Fetal hepatocytes were cultured in the absence control or in the
presence of 20 ngrml EGF andror 100 ngrml PDB for 24 h.
Cells were collected and treated for analysis of cell cycle as
described in Section 2. Results represent the % of cells in each
state and are the means"S.E.M. of three independent experi-
ments. Probability of significant differences from control cul-
tures: )P -0.05; ))P -0.01.
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ever, the fetal hepatocyte cell cycle was not significa-
tively affected by the presence of PDB, neither alone
 .nor in the presence of EGF Table 1 . These results
showed that phorbol esters do not regulate growth of
fetal hepatocytes.
4. Discussion
In the present study, we have used phorbol esters
to evaluate the role of protein kinase C pathway in
liver growth and specific gene expression during fetal
development. We have used fetal hepatocytes in pri-
mary culture because these cells are able to respond
to extracellular stimuli, inducing DNA synthesis
w x14,43 , but under appropriate conditions, they can
also differentiate, a process characterized by the ac-
quisition andror loss of gene expression observed
w xduring liver development in vivo 16–19 . For this,
the fetal hepatocyte culture model therefore ade-
quately reflects in vivo changes in developmentally
w xregulated liver-specific genes 44 .
We have found that when fetal hepatocytes, cul-
tured under proliferative conditions, i.e., in the pres-
ence of EGF, are incubated in the presence of PDB,
 .AFP mRNA levels decrease Fig. 1A . This effect,
which is dependent on protein kinase C activity Fig.
.1B and C , reflects the decrease we observed in the
 .transcriptional rate of the AFP gene Fig. 2 . In
contrast, albumin gene transcription is not affected.
Considering that AFP mRNA half-life is approxi-
w xmately of 27 h 45 , our data on AFP mRNA levels
 .Fig. 1A and AFP gene transcription in EGF plus
 .PDB treated hepatocytes Fig. 2 suggest an almost
total stop in transcription of the gene. Since transcrip-
tion of the AFP gene drops around birth and is totally
blocked during normal adult life, specific down-regu-
lation of AFP expression is always related to differ-
entiation or terminal maturation of fetal hepatocytes.
Previous studies had indicated that EGF and 12-
 .O-tetradecanoylphorbol-13-acetate TPA synergisti-
cally suppress enhancer and promoter activities of the
AFP gene in HuH-7 human hepatoma cells, reducing
w xits mRNA levels 46,47 . Under these conditions, no
effect was observed on the transcriptional regulatory
activity of up to 12 kb of the 5X-flanking sequence of
w xthe albumin gene 46 . Similar synergistic actions
between EGF and phorbol esters in regulating gene
expression have also been described for other hepatic
w xgenes, such as PEPCK in adult hepatocytes 48 .
The activation of PKC isoenzymes by phorbol
esters may be achieved within a wide range of con-
centrations for K values. The calcium-independentd
isoenzymes being those with the lower K valuesd
w x49 . Taken in account that PDB treatment caused its
 .effect at concentrations as low as 1 ngrml Fig. 1B
 .and that fetal hepatocytes contain mainly 70% these
 w x.type of isoenzymes Fig. 3, 50 , it seems likely that
the effect of PDB on AFP mRNA levels implies this
type of isoenzymes. PKC z is another isoenzyme
belonging to the group of atypical PKCs. It has been
w xrelated to activation of k B transcription factor 51
w xand proliferation 40 . Fetal hepatocytes, in our cul-
ture conditions, have already activated this isoen-
zyme, although we can not conclude the relevance of
the basal activity since both EGF and PDB were
unable to increase it. However, co-treatment of EGF
and PDB produced a 17% inhibition with respect to
control, which correlate with the decrease in AFP
mRNA levels.
Although EGF induces activation and translocation
of phospholipase C-g to the cytoskeleton in rat hepa-
w xtocytes 52 , it has been proposed that protein kinase
C is not necessarily involved in some of the short-term
action of physiological growth factors in these cells
w x53 . Thus, the synergistic effect between phorbol
esters and EGF is likely to be mediated by overlap-
ping and integrated signal transduction pathways pri-
marily involving protein kinase C and the tyrosine
kinase domain of the EGF receptor. A point of
convergence between these different signal transduc-
tion pathways may be ras activation, which stimu-
lates the expression and the activation of c-jun and
c-fos. JNK is responsible for phosphorylating the
w xtransactivating domain of JUN protein 54 and phos-
phorylated JUN as homodimer, or heterodimer with
FOS, have potent AP-1 activity, regulating the ex-
pression of a number of genes, including c-jun itself
w x55 . We show here that incubation of the hepatocytes
in the presence of both EGF and PDB clearly pro-
duces an activation of JNK and MAPK activities, an
enhancement in jun and fos mRNA levels and an
increase in AP-1 DNA binding activity, which is
higher than that observed by each one of those
 .factors acting independently Figs. 4–6 . This might
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indicate the co-existence of independent signalling
pathways from the cell surface to the nucleus in the
regulation by PDB and EGF of fos and jun expres-
sion and activity. In agreement with this, Rozengurt
w xand Sinnett-Smith 56 had observed that down-regu-
lation of PKC completely blocked the induction of
c-fos produced by PDB in Swiss 3T3 cells, but did
not affect the induction of c-fos promoted by EGF.
w xNakao et al. 57 have described that mutant ras
 .Val-12 suppressed the expression of the AFP gene,
but not the albumin gene, in HuH-7 hepatoma cells.
Over-expression of c-jun also specifically repressed
the rat AFP promoter but not the albumin promoter,
w xin HepG2 hepatoma cells 58 . Taking these data
together, we can suggest that EGF and PDB down-
regulation of AFP expression in fetal hepatocytes
might be mediated through a cooperative activation
of ras pathway, JNK and MAPK activities, fos and
jun expression and AP-1 DNA binding activity. Im-
plication of MAPK activated by EGF seems obvious,
since the inhibitor PD98059 totally blocked the syn-
ergistic effect of EGF and PDB on AFP mRNA
 .levels Fig. 6B . Obviously, the possible role of other
transcription factors cannot be excluded.
Treatment of different cell types with phorbol
esters can produce various effects on their growth
and differentiation. Numerous studies have demon-
strated that phorbol esters may act as potent mitogens
and inhibitors of differentiation in some established
w xcell lines 10,11 . However, phorbol esters may also
inhibit growth or act as promoters of differentiation
w xin other cell lines 12 . Phorbol esters effects on liver
growth are controversial at the moment. Although
some authors describe that they may be mitogens for
w x w xneonatal 59 or adult 60 hepatocytes and for some
w xhepatoma cells 61 , others observed that they have
w xnot any effect in hepatocytes 62 or even inhibit
w x w xgrowth of other human 63 or rat 64 hepatoma cell
lines. In the present work, we show that in fetal
hepatocytes, phorbol esters neither increase nor in-
hibit the proliferation induced by EGF Fig. 7, Table
.1 . Furthermore, experiments performed in our labo-
ratory have shown that specific inhibition of protein
kinase C, by using BIS, does not affect DNA synthe-
 .sis induced by this growth factor results not shown .
Thus, protein kinase C does not seem to regulate
growth of fetal hepatocytes in primary culture. Both,
EGF and PDB activate MAPK which have been
implicated in both proliferation and differentiation
w xprocesses 65,66 . In fetal hepatocytes, activation of
MAPK by EGF is clearly implicated in proliferation
of hepatocytes, since inhibition of MEK with
PD98059 totally blocked EGF effect. However, acti-
vation of MAPK by PDB does not correlates with
 .proliferation Figs. 6 and 7 . Since EGF and PDB
activated specifically in each case signalling path-
ways other than the MAPK pathway, we conclude
that mechanisms in addition to MAPK action must be
taken into account to explain their global effects on
hepatocyte proliferation and differentiation.
Roles for c-jun and c-fos in hepatocyte develop-
ment have been proposed after the observation that
their mRNAs are induced immediately after partial
hepatectomy with a concomitant increase in c-jun
w xkinase and AP-1 binding activity 67 . It is presumed
that the function of such immediate early response
products is to serve as activators of genes required
for cell division, but the genetic targets controlled by
AP-1 are not completely known. Gene targeting stud-
ies have showed that homozygous mutation of the
c-jun gene leads to embryonic lethality and, most
striking, severe hypoplasia of the liver parenchyma
w x68 . These authors showed that c-jun may be re-
quired by early hepatocytes for liver development.
The results presented in this paper suggest that acti-
vation of protein kinase C pathway may, at least, play
a key role in the process of liver differentiation,
down-regulating specifically alpha-fetoprotein gene
expression without affecting growth of fetal liver
cells.
Acknowledgements
The authors wish to thank Dr. A.M. Alvarez
Centro de Citometria de Flujo y Microscopıa Confo-´
.cal, U.C.M. for the expert technical assistance with
the flow cytometer and Drs. S. Gutkind, E. Rozengurt
and M. Yaniv for providing plasmids and Drs. H.L.
Leffert and L. Bosca for helpful discussions. The´
studies presented in this report were supported by a
grant from the Fondo de Investigaciones Sanitarias,
Ministerio de Sanidad y Consumo 95r1530, Spain
and a Joint Action between France and Spain Picasso
.Programme . JLD also acknowledges the financial
support from the French Association Pour la
( )C. Roncero et al.rBiochimica et Biophysica Acta 1402 1998 151–164162
Recherche Contre le Cancer. M.L.M. and J.-J.V.
were recipients of fellowships from the Ministerio de
Educacion y Ciencia, Spain. A.S. was recipient of a´
fellowship from the Comunidad de Madrid.
References
w x1 S. Sell, M. Nichols, F.F. Becker, H.L. Leffert, Hepatocyte
proliferation and a1-fetoprotein in pregnant, neonatal, and
 .partially hepatectomized rats, Cancer Res. 34 1974 865–
871.
w x2 I. Tournier, L. Legres, D. Schoevaert, G. Feldman, D.
Bernuau, Cellular analysis of a-fetoprotein gene activation
during carbon tetrachloride and D-galactosamine-induced
 .acute liver injury in rats, Lab. Invest. 59 1988 657–665.
w x3 J. Papaconstantinou, J.P. Rabek, D.-E. Zhang, Molecular
mechanisms of liver-specific albumin and alpha-fetoprotein
 .gene regulation: a review, Dev. Growth Differ. 32 1990
205–216.
w x4 M. Jose-Estanyol, J.-L. Danan, A liver-specific factor and
nuclear factor I bind to the rat a-fetoprotein promoter, J.
 .Biol. Chem. 263 1988 10865–10871.
w x5 M. Jose-Estanyol, A. Poliard, D. Foiret, J.-L. Danan, A
common liver-specific factor binds to the rat albumin and
a-foetoprotein promoters in vitro and acts as a positive
 .transacting factor in vivo, Eur. J. Biochem. 181 1989
761–766.
w x6 M.H. Feuerman, R. Godbout, R.S. Ingram, S.M. Tilghman,
Tissue-specific transcription of the mouse a-fetoprotein gene
 .promoter is dependent on HNF-1, Mol. Cell. Biol. 11 1989
4204–4212.
w x7 D.-E. Zhang, P.R. Hoyt, J. Papaconstantinou, Localization
of DNA protein-binding sites in the proximal and distal
promoter regions of the mouse a-fetoprotein gene, J. Biol.
 .Chem. 265 1990 3382–3390.
w x8 H. Thomassin, D. Hamel, D. Bernier, M. Guertin, L. Belan-´
ger, Molecular cloning of two CrEBP-related proteins that
bind to the promoter and the enhancer of the a1-fetoprotein
gene. Further analysis of CrEBP b and CrEBP g , Nucleic
 .Acids Res. 20 1992 3091–3098.
w x9 B. Bois-Joyeux, J.-L. Danan, Members of the CAATren-
hancer-binding protein, hepatocyte nuclear factor-1 and nu-
clear factor-1 families can differentially modulate the activi-
ties of the rat a-fetoprotein promoter and enhancer,
 .Biochem. J. 301 1994 49–55.
w x10 D. Ishii, E. Fibach, H. Yamasaki, I.B. Weinstein, Tumor
promoters inhibit morphological differentiation in cultures
 .mouse neuroblastoma cells, Science 200 1978 556–559.
w x11 P. Dicker, E. Rozengurt, Phorbol esters and vasopressin
stimulate DNA synthesis by a common mechanism, Nature
 .287 1980 607–612.
w x12 C.L. Huang, H.E. Ives, Growth inhibition by protein kinase
 .C late in mitogenesis, Nature 329 1987 849–850.
w x13 Y. Nishizuka, Protein kinase C and lipid signalling for
 .sustained cellular responses, FASEB J. 9 1995 484–496.
w x14 C. De Juan, M. Benito, A. Alvarez, I. Fabregat, Differential
proliferative response of cultured fetal and regenerating
hepatocytes to growth factors and hormones, Exp. Cell. Res.
 .202 1992 495–500.
w x15 I. Fabregat, C. de Juan, T. Nakamura, M. Benito, Growth
stimulation of rat fetal hepatocytes in response to hepatocyte
growth factor: modulation of c-myc and c-fos expression,
 .Biochem. Biophys. Res. Commun. 189 1992 684–690.
w x16 L.L. Shelly, W. Tynan, W. Schmid, G. Schutz, G.C.T.¨
Yeoh, Hepatocyte differentiation in vitro: initiation of tyro-
sine aminotransferase expression in cultured fetal rat hepato-
 .cytes, J. Cell. Biol. 109 1989 3403–3410.
w x17 B. Hoffmann, D. Paul, Precocious induction of tyrosine
aminotransferase mRNA by hydrocortisone in cultured fetal
rat hepatocytes at different developmental stages, J. Cell.
 .Physiol. 143 1990 352–356.
w x18 C. De Juan, M. Benito, I. Fabregat, Regulation of albumin
expression in fetal rat hepatocytes cultured under prolifera-
tive conditions: role of epidermal growth factor and hor-
 .mones, J. Cell. Physiol. 152 1992 95–101.
w x19 A. Sanchez, A.M. Alvarez, M. Benito, I. Fabregat, Trans-´
forming growth factor b modulates growth and differentia-
tion of fetal hepatocytes in primary culture, J. Cell. Physiol.
 .165 1995 398–405.
w x20 H.L. Leffert, D. Paul, Studies on primary cultures of differ-
 .entiated fetal liver cells, J. Cell. Biol. 52 1972 559–568.
w x21 C. Roncero, M. Lorenzo, I. Fabregat, M. Benito, Rates of
lipogenesis in fetal hepatocytes in suspension and in primary
culture: hormonal effects, Biochim. Biophys. Acta 1012
 .1989 320–324.
w x22 L.L. Jagodinski, T.D. Sargent, M. Yang, C. Glackin, J.
Bonner, Sequence homology between RNAs encoding rat
a-fetoprotein and rat serum albumin, Proc. Natl. Acad. Sci.
 .U.S.A. 78 1981 3521–3525.
w x23 T.D. Sargent, J.R. Wu, J.M. Sala-Trepat, R.B. Wallace,
A.A. Reyes, J. Bonner, The rat serum albumin gene: analy-
sis of cloned sequences, Proc. Natl. Acad. Sci. U.S.A. 76
 .1979 3256–3260.
w x24 N.E. Cooke, Rat vitamin D binding protein. Determination
of the full-length primary structure from cloned cDNA, J.
 .Biol. Chem. 261 1986 3441–3450.
w x25 J.L. Danan, V. Ribeiro, M.C. Lechner, D. Pompon, Expres-
sion of the rat vitamin D binding protein gene, in: A.W.
 .Norman, R. Bouillon, M. Thomasset, W. de Gruyter Eds. ,
Vitamin D, Berlin, 1991, pp. 697–698.
w x26 S.I. Hirai, B. Bourachot, M. Yaniv, Both jun and fos
contribute to transcription activation by the heterodimer,
 .Oncogene 5 1990 39–46.
w x27 F. Van Straaten, R. Muller, T. Currar, C. Van Beveren, I.M.¨
Verma, Complete nucleotide sequence of a human c-onc
gene: Deduced amino acid sequence of the human c-fos
 .protein, Proc. Natl. Acad. Sci. U.S.A. 80 1983 3183–3187.
w x28 D.R. Edwards, G. Murphy, J.J. Reynolds, S.E. Whitham,
A.J.P. Docherty, P. Angel, J.K. Heath, Transforming growth
( )C. Roncero et al.rBiochimica et Biophysica Acta 1402 1998 151–164 163
factor b modulates the expression of collagenase and metal-
 .loproteinase inhibitor, EMBO J. 6 1987 1899–1904.
w x29 P. Chomczynski, N. Sacchi, Single-step method of RNA
isolation by acid guanidinium thiocyanate–phenol–chloro-
 .form extraction, Anal. Biochem. 162 1987 156–159.
w x30 U. Schibler, O. Hagenbuchle, P.K. Wellauer, A.C. Pitte,
Two promoters of different strengths control the transcrip-
tion of the mouse alpha-amylase gene Amy-1a in the parotid
 .gland and the liver, Cell 33 1983 501–508.
w x31 S.R. Stapleton, D.A. Mitchell, L. Salati, A.G. Goodridge,
Triiodothyronine stimulates transcription of the fatty acid
synthase gene in chick embryo hepatocytes in culture. In-
sulin and insulin-like growth factor amplify that effect, J.
 .Biol. Chem. 265 1990 18442–18446.
w x32 M. Linial, N. Gunderson, M. Groudine, Enhanced transcrip-
tion of c-myc in bursal lymphoma cells requires continuous
 .protein synthesis, Science 230 1985 1126–1132.
w x33 C. Roncero, A.G. Goodridge, Regulation of the malic en-
zyme and fatty acid synthase genes in chick embryo hepato-
cytes in culture: corticosterone and carnitine regulate re-
sponsiveness to triiodothyronine, Arch. Biochem. Biophys.
 .295 1992 258–267.
w x34 M. Junco, M.J.M. Diaz-Guerra, L. Bosca, Differential cal-
cium mobilization by Vasopressin, Angiotensin II, Gastrin-
releasing peptide, and adenosine triphosphate in adult and
 .fetal hepatocytes, Endocrinology 132 1993 309–318.
w x35 A. Porras, K. Musynsky, U.R. Rapp, E. Santos, Dissociation
between activation of Raf-1 kinase and the 42 kDa
mitogen-activated protein kinaser90-kDa S6 kinase
 .MAPKrRSK cascade in the insulinrras pathway of
adipocytic differentiation of 3t3 L1 cells, J. Biol. Chem. 269
 .1994 12741–12748.
w x36 N.C. Andrews, D.V. Faller, A rapid micropreparation tech-
nique for extraction of DNA-binding proteins from limiting
 .numbers of mammalian cells, Nucleic Acids Res. 19 1991
2499.
w x37 P. Wen, J. Locker, A novel hepatocytic transcription factor
that binds the a-fetoprotein promoter-linked coupling ele-
 .ment, Mol. Cell. Biol. 14 1994 6616–6626.
w x38 A. Sanchez, A.M. Alvarez, M. Benito, I. Fabregat, Apopto-´
sis induced by transforming growth factor-b in fetal hepato-
cyte primary cultures. Involvement of reactive oxygen inter-
 .mediates, J. Biol. Chem. 271 1996 7416–7422.
w x39 D. Toullec, P. Pianetti, H. Coste, P. Bellevergue, T. Grand-
Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F.
Loriolle, L. Duhamel, D. Charon, J. Kirilovsky, The bisin-
dolylmaleimide GF 109203X is a potent and selective in-
 .hibitor of protein kinase C, J. Biol. Chem. 266 1991
15771–15781.
w x40 A.M. Valverde, T. Teruel, M. Lorenzo, M. Benito, Involve-
ment of Raf-1 kinase and protein kinase C z in insulin-like
growth factor I-induced brown adipocyte mitogenic sig-
nalling cascades: inhibition by cyclic adenosine 3X,5X-mono-
 .phosphate, Endocrinology 137 1996 3832–3841.
w x41 P. Angel, M. Karin, The role of jun, fos and the AP-1
complex in cell-proliferation and transformation, Biochim.
 .Biophys. Acta 1072 1991 129–157.
w x42 D.R. Alesi, A. Cuenda, P. Cohen, D.T. Dudley, A.R. Saltiel,
PD98059 is a specific inhibitor of the activation of
mitogen-activated protein kinase in vitro and in vivo, J.
 .Biol. Chem. 270 1995 27489–27491.
w x43 H.L. Leffert, Growth control of differentiated fetal rat hepa-
tocytes in primary monolayer culture: V. Occurrence in
dialyzed fetal bovine serum of macromolecules having both
positive and negative growth regulatory functions, J. Cell.
 .Biol. 62 1974 767–779.
w x44 E.A. Milward, G.C. Yeoh, Expression of a-fetoprotein by
differentiating fetal rat hepatocytes in vitro, Eur. J. Cell.
 .Biol. 52 1990 185–192.
w x45 L. Berlanger, M. Frain, P. Baril, M.C. Gingras, J.
Bartkowiak, J.M. Sala-Trepat, Glucocorticosteroid suppres-
sion of alpha-fetoprotein synthesis in developing rat liver.
Evidence of a selective gene repression at the transcriptional
 .level, Biochemistry 20 1981 6665–6672.
w x46 K. Nakata, M. Motomura, H. Nakabayashi, A. Ido, T.
Tamaoki, A possible mechanism of inverse developmental
regulation of a-fetoprotein and albumin genes, J. Biol.
 .Chem. 267 1992 1331–1334.
w x47 P. Arbuthnot, M.-P. Bralet, H. Thomassin, J.-L. Danan, C.
Brechot, N. Ferry, Hepatoma cell-specific expression of a´
retrovirally transferred gene is achieved by a-fetoprotein but
not insulin-like growth factor II regulatory sequences, Hepa-
 .tology 22 1995 1788–1796.
w x48 C. Fillat, A. Valera, F. Bosch, Epidermal growth factor
inhibits phosphoenol-pyruvate carboxykinase gene expres-
sion in rat hepatocytes in primary culture, FEBS Lett. 318
 .1993 287–291.
w x49 C. Marquez, C. Martinez-A, G. Kroemer, L. Bosca, Protein
kinase C isoenzymes display differential affinity for phorbol
 .esters, J. Immunol. 149 1992 2560–2568.
w x50 M. Goldberg, S.F. Steinberg, Tissue-specific developmental
regulation of protein kinase C isoforms, Biochem. Pharma-
 .col. 51 1996 1089–1093.
w x51 M.T. Diaz-Meco, E. Berra, M.M. Municio, L. Sanz, J.
Lozano, I. Dominguez, V. Diaz-Golpe, M.T. Lain, J. Al-
cami, F. Arenzana, C.V. Paya, J.L. Virelizier, J. Moscat,
Dominant negative protein kinase C subspecies blocks NF-
 .kB activation, Mol. Cell. Biol. 13 1993 4770–4775.
w x52 L.J. Yang, S.G. Rhee, J.R. Williamson, Epidermal growth
factor-induced activation and translocation of phopholipase
C-g1 to the cytoskeleton in rat hepatocytes, J. Biol. Chem.
 .269 1994 7156–7162.
w x53 W.J. Vaartjes, C.G. de Haas, S.G. van den Bergh, Phorbol
esters, but not epidermal growth factor or insulin, rapidly
decrease soluble protein kinase C activity in rat hepatocytes,
 .Biochem. Biophys. Res. Commun. 138 1986 1328–1333.
w x54 B. Derijard, M. Hibi, I.-H. Wu, T. Barret, B. Su, T. Deng,´
M. Karin, R.J. Davis, JNK1:a protein kinase stimulated by
UV light and Ha-Ras that binds and phosphorylates the
 .c-jun activation domain, Cell 76 1994 1025–1037.
( )C. Roncero et al.rBiochimica et Biophysica Acta 1402 1998 151–164164
w x55 P. Angel, K. Hattori, T. Smeal, M. Karin, The jun pro-
tooncogen is positively autoregulated by its product jun-
 .AP1, Cell 55 1988 875–885.
w x56 E. Rozengurt, J. Sinnet-Smith, Early signals underlying the
induction of the proto-oncogenes c-fos and c-myc in quies-
cent fibroblasts: studies with peptides of the bombesin fam-
ily and other growth factors, Prog. Nucleic Acid Res. Mol.
 .Biol. 35 1988 261–295.
w x57 K. Nakao, D. Lawless, Y. Ohe, Y. Miyao, H. Nakabayashi,
H. Kamiya, K. Miura, E. Ohtsuka, T. Tamaoki, c-Ha-ras
down regulates the a-fetoprotein gene but not the albumin
 .gene in human hepatoma cells, Mol. Cell. Biol. 10 1990
1461–1469.
w x58 B. Bois-Joyeux, M. Denissenko, H. Thomassin, S. Guesdon,
R. Ikonomova, D. Bernuau, G. Feldman, J.- L Danan, The
c-jun proto-oncogene down-regulates the rat a-fetoprotein
promoter in HepG2 hepatoma cells without binding to DNA,
 .J. Biol. Chem. 270 1995 10204–10211.
w x59 U. Armato, P.G. Andreis, F. Romano, The stimulation by
the tumour promoters 12-O-tetradecanoyl-phorbol-13-acetate
and phenobarbital of the growth of primary neonatal rat
 .hepatocytes, Carcinogenesis 6 1985 811–821.
w x60 N. Sawada, J.L. Staecker, H.C. Pitot, H.C. Effects of
tumor-promoting agents, 12-O-tetradecanoylphorbol-13-
acetate and phenobarbital on DNA synthesis of rat hepato-
 .cytes in primary culture, Cancer Res. 47 1987 5665–5671.
w x61 J.L. Messina, J.A. McCann, Interaction of insulin and phor-
bol esters on the regulation of DNA synthesis in rat hep-
 .atoma cells, Biochem. Biophys. Res. Commun. 172 1990
759–766.
w x62 H.L. Leffert, K.S. Koch, X.P. Lu, D.A. Brenner, M. Karin,
H.F. Skelly, R.A. Rippe, G. Fey, M. Chojkier, Cellular and
molecular biology of hepatocyte growth, regeneration and
 .gene expression, in: Y. Hishizuka et al. Eds. , The Biology
and Medicine of Signal Transduction 94, Raven Press, New
York, 1990.
w x63 V. Duronio, B.E. Huber, S. Jacobs, Partial down-regulation
of protein kinase C reverses the growth inhibitory effect of
 .phorbol esters on HepG2 cells, J. Cell. Physiol. 145 1990
381–389.
w x64 R. Taub, A. Roy, R. Dieter, J. Koontz, Insulin as a growth
factor in rat hepatoma cells. Stimulation of proto-oncogene
 .expression, J. Biol. Chem. 262 1987 10893–10897.
w x65 J. Font de Mora, A. Porras, N. Ahn, E. Santos, Mitogen-
activated protein kinase activation is not necessary for, but
antagonizes, 3T3-L1 adipocytic differentiation, Mol. Cell.
 .Biol. 17 1997 6068–6075.
w x66 S. Cowley, H. Paterson, P. Kemp, C.J. Marshall, Activation
of MAP kinase is necessary and sufficient for PC12 differ-
entiation and for transformation of NIH 3T3 cells, Cell 77
 .1994 841–852.
w x67 J.K. Westwick, C. Weitzel, H.L. Leffert, D.A. Brenner,
Activation of jun kinase is an early event in hepatic regen-
 .eration, J. Clin. Invest. 95 1995 803–810.
w x68 F. Hilberg, A. Aguzzi, N. Howells, E.F. Wagner, c-jun is
essential for normal mouse development and hepatogenesis,
 .Nature 365 1993 179–181.
